Investment
Features
FeesSafety
Academy
More
Pluang+

Wildpack Beverage's lender forecloses; all directors and officers resign, company left with no assets or operations.

Market News
17 Sep 2026
TheNewswire
View Source
Bearish
Wildpack Beverage's lender forecloses; all directors and officers resign, company left with no assets or operations.

Wildpack Beverage Inc. announced that all its directors and officers have resigned, leaving the company without leadership. This follows the completion of foreclosure by its secured lender, Sandton Capital Solutions Master Fund V, LP, due to defaults on a $95 million loan. The lender has taken full control of the company's assets, effectively leaving Wildpack with no remaining assets or operations. The company previously provided beverage manufacturing and packaging services but now faces an uncertain future with no management or assets.

Wildpack Beverage Inc.'s recent leadership resignations and lender foreclosure provide context for the broader Consumer Cyclical sector. For readers following this sector, here is Pluang's market snapshot as of Sep 18, 2026 05:01 WIB: Among 105 priced Consumer Cyclical US stocks tradable on Pluang, 54 rose and 49 fell today. Notable movers include Quantumscape Corp (QS) at USD 5.17 with a 3.40% increase and 100% buy order activity, Best Buy Co Inc (BBY) at USD 94.40 with a 3.18% increase and 100% buy order activity, and Allbirds Inc (BIRD) at USD 2.44 with a 3.16% decrease and 100% sell order activity.

More News

RBC Capital raises Amgen price target to $430 on strong earnings outlook

RBC Capital raises Amgen price target to $430 on strong earnings outlook

RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...

Analyst Insights
Bullish
52 minutes ago
Tilray misses Q1 earnings estimates despite revenue growth, cuts debt, and maintains 2027 EBITDA forecast.

Tilray misses Q1 earnings estimates despite revenue growth, cuts debt, and maintains 2027 EBITDA forecast.

Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...

Company Fundamentals
Bearish
57 minutes ago
UnitedHealth Group Q3 earnings preview: $4.12 EPS expected, focus on Medicare Advantage trends and medical costs.

UnitedHealth Group Q3 earnings preview: $4.12 EPS expected, focus on Medicare Advantage trends and medical costs.

UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...

Company Fundamentals
Neutral
1 hour ago
Fieldstone Bio joins Rio Tinto accelerator to advance biosensor tech for faster mineral exploration.

Fieldstone Bio joins Rio Tinto accelerator to advance biosensor tech for faster mineral exploration.

Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...

Market News
Bullish
1 hour ago
Dividend 15 Split Corp. renews ATM equity program to raise up to $600M through share sales until 2028

Dividend 15 Split Corp. renews ATM equity program to raise up to $600M through share sales until 2028

Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App